Inputs
Example data table
| Scenario | C (mg/L) | IR (L/day) | EF (days/year) | ED (years) | BW (kg) | RfD (mg/kg-day) | Notes |
|---|---|---|---|---|---|---|---|
| Adult, steady exposure | 0.05 | 2.0 | 350 | 30 | 70 | 0.003 | Common ingestion-style assumptions. |
| Child, higher intake per kg | 0.05 | 1.0 | 350 | 6 | 15 | 0.003 | Lower BW increases CDI and HQ. |
| Seasonal exposure | 0.05 | 2.0 | 120 | 10 | 70 | 0.003 | Lower EF reduces CDI proportionally. |
Formula used
This tool estimates non-cancer risk using the ingestion pathway. It first computes the chronic daily intake (CDI), then divides by the reference dose (RfD).
- CDI (mg/kg-day) = (C × IR × EF × ED) / (BW × AT)
- HQ = CDI / RfD
- Cmax (for HQ = 1) = (RfD × BW × AT) / (IR × EF × ED)
C is concentration (mg/L), IR is intake (L/day), EF is days/year, ED is years, BW is kg, and AT is averaging time in days.
How to use this calculator
- Enter the chemical concentration and the intake rate.
- Set exposure frequency and duration for your scenario.
- Provide body weight and an authoritative reference dose.
- Use non-cancer averaging time, or choose custom.
- Click Calculate, then export results as CSV or PDF.
Exposure inputs should match the route
Hazard quotient screening is only as reliable as its exposure story. For drinking-water ingestion, concentration in mg/L pairs naturally with intake in L/day. If you are evaluating food, soil, or air, convert to a compatible concentration unit and intake rate before using the same structure. Document the pathway, receptor, and any dilution or treatment assumptions.
Chronic daily intake explains the scaling
The calculator computes chronic daily intake by multiplying concentration, intake rate, exposure frequency, and exposure duration, then dividing by body weight and averaging time. This structure makes the sensitivity intuitive: doubling concentration doubles intake; halving body weight doubles intake. Averaging time smooths exposure across days, which is why non-cancer assessments commonly align averaging time to exposure duration.
Reference dose selection drives the benchmark
RfD is the toxicity benchmark used in the denominator, so it should come from an authoritative source and match the exposure route and duration. When multiple values exist, select the one applicable to chronic exposure and note any uncertainty factors. Using an inappropriate RfD can understate or overstate risk more than any reasonable exposure adjustment.
Interpreting HQ values for decisions
HQ is unitless. Values below one are typically interpreted as unlikely to pose non-cancer adverse effects for the modeled receptor, while values above one suggest potential concern and a need for refinement. Refinement may include better sampling data, receptor-specific intake estimates, alternative exposure frequencies, or the addition of site controls that reduce concentration or contact.
Using the target concentration output wisely
The tool also back-calculates a target concentration that would yield HQ equal to one for the same assumptions. This is useful for setting provisional screening levels, comparing treatment goals, or communicating “what-if” reductions. Because the target depends on every input, treat it as scenario-specific and always report the full parameter set alongside the target value.
To support audits, store the calculation date, chemical identifier, and units used. If you evaluate several chemicals, compute a hazard index by summing HQs for common target organs. Pair results with confidence notes: sampling variability, detection limits, and conservative defaults. This transparency helps reviewers understand why a value materially changed between iterations over time.
FAQs
What does HQ represent in this tool?
HQ compares estimated chronic intake to a reference dose. It is a screening indicator for non-cancer effects and helps prioritize whether an exposure scenario needs refinement or mitigation.
Why can HQ increase when body weight decreases?
CDI is normalized by body weight. With the same concentration and intake, a smaller body weight yields a higher mg/kg-day dose, so HQ rises proportionally.
Should averaging time always equal exposure duration?
For many non-cancer chronic assessments, averaging time is set to exposure duration. Use a custom averaging time when guidance or study design requires a different averaging window.
How do I handle intermittent or seasonal exposure?
Adjust exposure frequency to reflect days per year of contact. Keep the same concentration unit and intake rate for the pathway, then recalculate to see how HQ changes with EF.
What if I have multiple chemicals in the same sample?
Calculate HQ for each chemical using its own reference dose. If they affect the same target organ or endpoint, sum the HQ values to estimate a simple hazard index for screening.
Is HQ below 1 always safe?
Not always. HQ depends on assumptions, data quality, and the selected reference dose. Treat HQ below 1 as lower concern, then confirm with better measurements, site context, and applicable guidance.